Behavioral
Salience
Salience is a behavioral intervention with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
BEHAVIORAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
completed375%
active_not_recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
active_not_recruitingnot_applicable
Validation of a Training Program for Patients With Alcohol Use Disorder
NCT03765476
completednot_applicable
Flu Shot Pre-visit Questionnaire
NCT05508698
completednot_applicable
Targeting Cognitive Immunization in Depression
NCT03460574
completednot_applicable
MINDSPACE Strategy for Risk Optimization
NCT02721446
Clinical Trials (4)
Showing 4 of 4 trials
NCT03765476Not Applicable
Validation of a Training Program for Patients With Alcohol Use Disorder
NCT05508698Not Applicable
Flu Shot Pre-visit Questionnaire
NCT03460574Not Applicable
Targeting Cognitive Immunization in Depression
NCT02721446Not Applicable
MINDSPACE Strategy for Risk Optimization
All 4 trials loaded
Drug Details
- Intervention Type
- BEHAVIORAL
- Total Trials
- 4